Varshosaz J et al. |
Physicochemical, Pharmacodynamic and Pharmacokinetic Characterization of Soluplus Stabilized Nanosuspension of Tacrolimus. |
2017 |
Curr Drug Deliv |
pmid:27697037
|
Liu C et al. |
Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone. |
2017 |
Pediatr. Neurol. |
pmid:29074055
|
Cheung AY et al. |
Probable Donor-Derived Cytomegalovirus Disease After Keratolimbal Allograft Transplantation. |
2017 |
Cornea |
pmid:28614157
|
Weir MR et al. |
Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial. |
2017 |
Transplantation |
pmid:26950714
|
Jouve T et al. |
New formulations of tacrolimus and prevention of acute and chronic rejections in adult kidney-transplant recipients. |
2017 |
Expert Opin Drug Saf |
pmid:28494654
|
Wolfshohl JA et al. |
Improvement of erythema dyschromicum perstans using a combination of the 1,550-nm erbium-doped fractionated laser and topical tacrolimus ointment. |
2017 |
Lasers Surg Med |
pmid:27552666
|
Sanghavi K et al. |
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients. |
2017 |
Pharmacogenomics J. |
pmid:26667830
|
Heemann U and Viklicky O |
Is trough level variability the new tool for identifying patients at risk for rejection after transplantation? |
2017 |
Nephrol. Dial. Transplant. |
pmid:28186537
|
Størset E et al. |
Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'. |
2017 |
Br J Clin Pharmacol |
pmid:28374426
|
Kizilbash SJ et al. |
Infection rates in tacrolimus versus cyclosporine-treated pediatric kidney transplant recipients on a rapid discontinuation of prednisone protocol: 1-year analysis. |
2017 |
Pediatr Transplant |
pmid:28371243
|
Ikeda K et al. |
Intestinal perforation due to hemorrhagic Cytomegalovirus enteritis in a patient with severe uncontrolled lupus nephritis: a case and review of the literature. |
2017 |
Rheumatol. Int. |
pmid:28283734
|
Hamada T et al. |
Phenotypic analysis of circulating T-cell subset and its association with burden of skin disease in patients with chronic actinic dermatitis: a hematologic and clinicopathologic study of 20 subjects. |
2017 |
Int. J. Dermatol. |
pmid:28176301
|
Piotti G et al. |
Once-daily prolonged-release tacrolimus formulations for kidney transplantation: what the nephrologist needs to know. |
2017 |
J. Nephrol. |
pmid:27206763
|
Ma TK et al. |
Therapeutic drug monitoring of once-daily tacrolimus (Advagraf) in a gastrectomized kidney transplant recipient. |
2017 |
Nephrology (Carlton) |
pmid:28064453
|
Percy C et al. |
Impact of Acute Infection Requiring Hospitalization on Tacrolimus Blood Levels in Kidney Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:29149962
|
Obaidat RM et al. |
Using Supercritical Fluid Technology (SFT) in Preparation of Tacrolimus Solid Dispersions. |
2017 |
AAPS PharmSciTech |
pmid:27116202
|
de Menezes AF et al. |
Pharmacologic Treatment of Vitiligo in Children and Adolescents: A Systematic Review. |
2017 |
Pediatr Dermatol |
pmid:27878842
|
Taber DJ et al. |
A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients. |
2017 |
Clin J Am Soc Nephrol |
pmid:27979979
|
Ganschow R et al. |
Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study. |
2017 |
Pediatr Transplant |
pmid:28714558
|
Tsunashima D et al. |
Development of extended-release solid dispersion granules of tacrolimus: evaluation of release mechanism and human oral bioavailability. |
2017 |
J. Pharm. Pharmacol. |
pmid:28872687
|